Latest AI and machine learning research in oncology/hematology for healthcare professionals.
The landscape of asthma management is undergoing significant transformation. This change is driven by several factors: deeper understanding of asthma pathophysiology, appreciation of the long-term harm of oral corticosteroids, biological treatments that dramatically improve patient outcomes with asthma remission becoming a realistic goal, and a focus on patient-centred care combined with the use o...
The objective of the study is to develop and validate a multiparametric MRI (mpMRI)-based model that integrated with habitat-based radiomics, deep transfer learning (DTL), and quantitative parameters for the preoperative prediction of extrathyroidal extension (ETE) in papillary thyroid carcinoma (PTC). This retrospective study collected clinical, pathological, and mpMRI data from patients with con...
Accurate preoperative assessment of CT-occult peritoneal metastasis (PM) in colorectal cancer is critical for clinical decision-making. This study dem...
The diagnosis of prostate cancer rests on the histopathological evaluation of prostate needle core biopsy specimens (NCBS) supplemented by immunohisto...
Contrast-enhanced computed tomography (CECT) of the abdomen and pelvis is widely used for diagnostic imaging but contributes substantially to cumulati...
INTRODUCTION: Breast cancer remains the most prevalent malignancy among women worldwide, with its pronounced molecular heterogeneity demanding therape...
OBJECTIVE: To develop and internally validate an explainable machine learning model for predicting textbook outcome (TO) after free flap reconstructio...
Single-cell RNA sequencing (scRNA-seq) enables high-resolution profiling of cellular heterogeneity, but integrating data across species remains challe...
INTRODUCTION: The survival rate of patients with life-threatening diseases primarily depends on the speed of diagnosis. Too often, diseases are detect...
BACKGROUND: The role of cytoreductive nephrectomy (CN) in metastatic papillary renal cell carcinoma (pRCC) remains poorly defined, as most CN evidence...
Immune checkpoint inhibitors, particularly antibodies targeting programmed cell death 1 (PD-1), are increasingly used for advanced hepatocellular carc...
BACKGROUND: SERPING1, which encodes the C1 inhibitor (C1-INH) of the complement system, and plays a key regulator in regulating inflammatory responses...
PURPOSE: Oral tongue squamous cell carcinoma (OTSCC) is characterized by aggressive local invasion and a high risk of cervical nodal metastasis and mo...
Acute Lymphoblastic Leukemia (ALL) is one of the most aggressive hematological malignancies, and its early diagnosis remains challenging due to non-sp...
Accurate multimodal deformable registration between magnetic resonance (MR) and computed tomography (CT) images is essential for precise target deline...
The integration of multiomics technologies with artificial intelligence (AI) has become a transformative force in modern precision medicine, particula...
Cancer patients are particularly susceptible to Drug-Drug Interactions (DDIs) due to frequent polypharmacy in oncology care. Co-administered drugs can...
BACKGROUND: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). However, a su...
BACKGROUND: Breast cancer transcriptional programs span malignant epithelial cells, and the tumor microenvironment (TME), yet tumor-normal contrasts a...
OBJECTIVE: This study aims to develop a data-driven methodology for stratifying Amyotrophic Lateral Sclerosis (ALS) patients based on longitudinal dis...